Updates are available Correction dated 2024-06-19
Click to view Correction: https://doi.org/10.1186/s13027-024-00589-0
-
Authors
Warden, Charles D.
Cholli, Preetam
Qin, Hanjun
Guo, Chao
Wang, Yafan
Kancharla, Chetan
Russell, Angelique M.
Salvatierra, Sylvana
Mutsvunguma, Lorraine Z.
Higa, Kerin K.
Wu, Xiwei
Wilczynski, Sharon
Pillai, Raju
Ogembo, Javier Gordon
-
Funding
Funding for this research was provided by:
National Cancer Institute (P30CA033572)
City of Hope
- License Information
-
More Information
Article History
Received: 10 April 2022
Accepted: 2 August 2022
First Online: 9 August 2022
Change Date: 19 June 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13027-024-00589-0
Declarations
:
: Because we used de-identified archived samples, this study was deemed Not Human Subjects Research and therefore exempt from additional oversight by the City of Hope Institutional Review Board (IRB Protocol #16142). This study assessed a mix of samples obtained with and without patient consent. General consent to participate was usually obtained using forms approved by the Institutional Review Board (IRB Protocol #07047, approval date: 06/21/2007). All archived DNA samples, obtained under IRB Protocol #89115, were from biospecimens collected in the first tumor bank at City of Hope as de-identified surgical discard material in the 1980s and 1990s, when individual patient consent for research purposes was not required. Frozen and FFPE tissue samples were procured through the City of Hope Biospecimen Repository Protocol. We were unable to verify the consent status for all samples (Additional File : Table S2). Consent for a subset of the most recent samples was validated through the honest broker system.
: Not applicable.
: The authors declare that they have no competing interests.
